KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Clínica Baviera, S.A. Stock and on which exchange is it traded?
The symbol for Clínica Baviera, S.A. is D9Z.F and it is traded on the FRA (Frankfurt Stock Exchange).

Should I buy or sell Clínica Baviera, S.A. Stock?
Clínica Baviera, S.A. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Clínica Baviera, S.A. Stock?
Clínica Baviera, S.A. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Clínica Baviera, S.A. Stock.

What's the current price of Clínica Baviera, S.A. Stock?
As of the end of day on the Jan 30, 2023, the price of an Clínica Baviera, S.A. (D9Z.F) share was 19.15€.

What is the 52-week high and low for Clínica Baviera, S.A. Stock?
The 52-week high for Clínica Baviera, S.A. Stock is 24.90€ and the 52-week low is 16.10€.
Click to get the best stock tips daily for free!

About Clínica Baviera, S.A.

Clínica Baviera S.A. Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, presbyopia, cataract, retina, pediatric ophthalmology, glaucoma, squint, cornea, neuroftalmología, vías lagrimales, and oculoplasty treatments. It operates approximately 90 centers in Spain, Germany, Aus... D9Z.F Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT